• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Oppenheimer Holdings Inc. Reports Second Quarter 2022 Earnings

    7/29/22 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance
    Get the next $OPY alert in real time by email

    NEW YORK, July 29, 2022 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported a net loss of $3.9 million or $(0.32) basic earnings per share for the second quarter of 2022, compared with net income of $31.2 million or $2.46 basic earnings per share for the second quarter of 2021. Revenue for the second quarter of 2022 was $237.2 million, a decrease of 30.3%, compared to revenue of $340.3 million for the second quarter of 2021.

    Albert G. Lowenthal, Chairman and CEO commented, "Macroeconomic factors drove lower results for the second quarter. While the economy continued to grow and unemployment remained at a record low level, waning consumer confidence, driven by high inflation and rising interest rates, created significantly higher volatility and markedly lower valuations in both equity and fixed income markets. The results for the quarter reflect the significant downturn in equity capital market issuance, which had an out-sized impact on the Company, compared to the prior year. By quarter's end, interest rates reached the highest levels since 2018 and higher mortgage rates were already impacting construction and home sales. While the Company's pipeline of potential future banking business remains strong, the closing of the window for IPOs and secondary offerings, and the closing down of the SPAC market, dramatically reduced capital markets revenues for the second quarter of 2022 compared to the second quarter of 2021. Higher interest rates and the beginning of quantitative tightening reduced bond issuance across markets, but particularly impacted the high yield and emerging markets as spreads off U.S. Treasuries widened dramatically during the quarter. These factors reduced revenues from capital markets (down 52%) for the quarter.

    Wealth Management continued to deliver solid results driven by continued high levels of assets under management but below recent all-time highs. The continued performance of our Wealth Management business and the increase in fees from our FDIC program offset some of the impact of lower revenue from capital markets as well as the increase in operating costs reflecting the inflationary environment, with the Firm showing a loss for the period. Declines in the Company's share price and equity prices in general had an outsized impact on the costs associated with deferred compensation plans and share awards during the period.

    Despite the unfavorable environment, the Company still maintains the strongest balance sheet and the highest capital level in its history. The Company took advantage of the lower level of its share price to purchase 885,230 shares (7%) of its Class A non-voting common shares at an average price of $34.13 in the open market under its share repurchase program. We remain confident in the resiliency of our platform and our ability to continue to provide essential investment services to our clients."

    Summary Operating Results (Unaudited)

    ('000s, except per share amounts or otherwise indicated)

    Firm

    2Q-22

    2Q-21

    Revenue

    $  237,222

    $ 340,293

    Compensation Expense

    $  177,979

    $ 231,140

    Non-compensation Expense

    $  65,412

    $  65,985

    Pre-Tax Income (Loss)

    $   (6,169)

    $  43,168

    Income Taxes Provision (Benefit)

    $   (1,449)

    $  12,009

    Net Income (Loss) (1)

    $   (3,874)

    $  31,159

    Earnings (Loss) Per Share (Basic) (1)

    $     (0.32)

    $      2.46

    Earnings (Loss) Per Share (Diluted) (1)

    $     (0.32)

    $      2.28

    Book Value Per Share

    $    68.57

    $    59.29

    Tangible Book Value Per Share (2)

    $    53.62

    $    45.90

    Private Client





    Revenue

    $  144,471

    $ 166,863

    Pre-Tax Income

    $  38,800

    $  21,673

    Assets Under Administration (billions)

    $    104.0

    $    117.3

    Asset Management





    Revenue

    $  24,315

    $  25,544

    Pre-Tax Income

    $    8,120

    $    8,638

    Assets Under Management (billions)

    $      37.1

    $      43.7

    Capital Markets





    Revenue

    $  71,274

    $ 147,945

    Pre-Tax Income (Loss)

    $ (17,935)

    $  39,373







    (1) Attributable to Oppenheimer Holdings Inc.

    (2) Represents book value less goodwill and intangible assets divided by number of shares outstanding.

     

    Highlights

    • Client assets under administration and under management were both at reduced levels at June 30, 2022 and also down from the first quarter of 2022 as well as the same period last year
    • Reduced second quarter 2022 gross revenue, net income, and earnings per share reflected a significant decline in industry-wide activity, and lower net revenue in underwriting, trading and M&A fees
    • The Company repurchased 885,230 shares of Class A non-voting common stock during the second quarter of 2022 under its previously announced buy-back plan or 7% of shares outstanding at year-end 2021, bringing the total shares purchased during the first 6 months of 2022 to 1,262,543
    • Book value and tangible book value per share reached record levels at June 30, 2022 largely as a result of share buybacks

    Private Client

    Private Client reported revenue for the current quarter of $144.5 million, 13.4% lower when compared with a year ago due to lower commissions as well as decreases in the cash surrender value of Company-owned life insurance policies, partially offset by an increase in bank deposit sweep income and higher average margin balances.  Pre-tax income of $38.8 million in the current quarter resulted in a pre-tax profit margin of 26.9%.  Financial advisor headcount at the end of the current quarter was 990 compared to 1,004 at the end of the second quarter of 2021.

    ('000s, except otherwise indicated)



    2Q-22

    2Q-21







    Revenue

    $144,471

    $166,863

    Commissions

    $45,916

    $53,753

    Advisory Fees

    $83,085

    $85,598

    Bank Deposit Sweep Income

    $14,845

    $  3,712

    Interest

    $10,369

    $  7,235

    Other

    $ (9,744)

    $16,565







    Total Expenses

    $105,671

    $145,190

    Compensation

    $77,342

    $117,564

    Non-compensation

    $28,329

    $  27,626







    Pre-Tax Income

    $38,800

    $21,673







    Compensation Ratio

    53.5 %

    70.5 %

    Non-compensation Ratio

    19.6 %

    16.6 %

    Pre-Tax Margin

    26.9 %

    13.0 %







    Assets Under Administration (billions)

    $104.0

    $117.3

    Cash Sweep Balances (billions)

    $7.5

    $7.3

     

    Revenue:

    • Retail commissions decreased 14.6% from a year ago due to a decrease in client activity compared to the significantly elevated levels from a year ago
    • Advisory fees decreased 2.9% due to lower assets under management
    • Bank deposit sweep income increased $11.1 million or 300% from a year ago due to higher balances and higher short-term interest rates
    • Interest revenue increased 43.3% from a year ago due to higher short-term interest rates and higher average margin balances
    • Other revenue decreased primarily due to decreases in the cash surrender value of Company-owned life insurance policies during the current period compared to increases in the value of those policies in the same period last year

    Total Expenses:

    • Compensation expenses decreased 34.2% from a year ago primarily due to decreased production, and decreased share-based and deferred compensation costs
    • Non-compensation expenses increased 2.5% from a year ago primarily due to higher interest, travel and legal expenses, offset by a decrease in allowance for credit losses

    Asset Management

    Asset Management reported revenue for the current quarter of $24.3 million, 4.8% lower compared with a year ago. Pre-tax income was $8.1 million, a decrease of 6.0% compared with the prior year period.

    ('000s, except otherwise indicated)



    2Q-22

    2Q-21







    Revenue

    $   24,315

    $   25,544

    Advisory Fees

    $   24,311

    $   25,541

    Other

    $             4

    $             3







    Total Expenses

    $   16,195

    $   16,906

    Compensation

    $      6,697

    $      6,261

    Non-compensation

    $      9,498

    $   10,645







    Pre-Tax Income

    $      8,120

    $      8,638







    Compensation Ratio

    27.5 %

    24.5 %

    Non-compensation Ratio

    39.1 %

    41.7 %

    Pre-Tax Margin

    33.4 %

    33.8 %







    AUM (billions)

    $        37.1

    $        43.7

     

    Revenue:

    • Advisory fee revenue decreased 4.8% due to lower net value of assets under management during the second quarter of 2022 compared with the second quarter of 2021

    Assets under Management (AUM):

    • AUM was at reduced levels of $37.1 billion at June 30, 2022, which is the basis for advisory fee billings for July 2022
    • The decrease in AUM was comprised of lower asset values of $6.0 billion on existing client holdings and a net distribution of assets of $0.6 billion

     Total Expenses:

    • Compensation expenses were up 7.0% from a year ago primarily due to increases in fixed compensation
    • Non-compensation expenses were down 10.8% when compared to the prior year period due to lower portfolio manager expense

    Capital Markets

    Capital Markets reported revenue for the current quarter of $71.3 million, 51.8% lower when compared with the prior year period.  Pre-tax loss was $17.9 million, compared with the pre-tax income of $39.4 million in the prior year period.

    ('000s)







    2Q-22

    2Q-21







    Revenue

    $ 71,274

    $147,945







    Investment Banking

    $ 14,699

    $ 99,045

    Advisory Fees

    $   8,284

    $ 50,515

    Equities Underwriting

    $   2,751

    $ 39,371

    Fixed Income Underwriting

    $   3,259

    $   8,835

    Other

    $      405

    $      324







    Sales and Trading

    $ 55,978

    $ 48,630

    Equities

    $ 37,126

    $ 30,218

    Fixed Income

    $ 18,852

    $ 18,412







    Other

    $      597

    $      270







    Total Expenses

    $ 89,209

    $108,572

    Compensation

    $ 67,172

    $ 85,663

    Non-compensation

    $ 22,037

    $ 22,909







    Pre-Tax Income (Loss)

    $(17,935)

    $ 39,373







    Compensation Ratio

    94.2 %

    57.9 %

    Non-compensation Ratio

    30.9 %

    15.5 %

    Pre-Tax Margin

    (25.2) %

    26.6 %

     

    Revenue:

    Investment Banking

    • Advisory fees earned from investment banking activities decreased 83.6% compared with a year ago. The high advisory fees from the prior year period were driven by large completed M&A transactions in healthcare, technology, and consumer products
    • Equity underwriting fees decreased 93.0% compared with a year ago due to a significant decrease in equity underwriting activity in the healthcare and technology sectors, particularly for SPAC issuances to access the public markets
    • Fixed income underwriting fees were down 63.1% compared with a year ago primarily driven by a decrease in public finance issuances and emerging market debt during second quarter of 2022

    Sales and Trading

    • Equities sales and trading revenue increased 22.9% compared with a year ago due to a marked increase in volatility in the equities market compared to the levels in the prior year period
    • Fixed Income sales and trading revenues increased by 2.4% compared with a year ago

    Total Expenses:

    • Compensation expenses decreased 21.6% compared with a year ago primarily due to decreased incentive compensation
    • Non-compensation expenses were 3.8% lower than a year ago due to a decrease in underwriting expenses, partially offset by an increase in business travel and entertainment expense

    Other Matters

    (In millions, except number of shares and per share amounts)



    2Q-22

    2Q-21

    Capital





    Shareholders' Equity (1)

    $      779.7

    $      752.5

    Regulatory Net Capital (2)

    $      435.6

    $      344.7

    Regulatory Excess Net Capital (2)

    $      404.0

    $      319.1







    Common Stock Repurchases





    Repurchases

    $        30.2

    $           —

    Number of Shares

    885,230

    —

    Average Price Per Share

    $      34.13

    $           —







    Period End Shares

    11,370,609

    12,692,311

    Effective Tax Rate

    23.5 %

    27.8 %







    (1) Attributable to Oppenheimer Holdings  Inc.

    (2) Attributable to Oppenheimer & Co. Inc. broker-dealer



    • The Board of Directors announced a quarterly dividend in the amount of $0.15 per share payable on August 26, 2022 to holders of Class A non-voting and Class B voting common stock of record on August 12, 2022
    • Compensation expense as a percentage of revenue was higher at 75.0% during the current period versus 67.9% during the same period last year due primarily to higher fixed compensation associated with salary increases granted in an inflationary environment and lower revenue
    • The effective tax rate for the current period was 23.5% compared with 27.8% for the prior year period and reflects the Company's estimate of the annual effective tax rate.

    Company Information

    Oppenheimer Holdings Inc., through its operating subsidiaries, is a leading middle market investment bank and full service broker-dealer that is engaged in a broad range of activities in the financial services industry, including retail securities brokerage, institutional sales and trading, investment banking (corporate and public finance), equity and fixed income research, market-making, trust services, and investment advisory and asset management services. With roots tracing back to 1881, the Company is headquartered in New York and has 91 retail branch offices in the United States and institutional businesses located in London, Tel Aviv, and Hong Kong.

    Forward-Looking Statements

    This press release includes certain "forward-looking statements" relating to anticipated future performance. For a discussion of the factors that could cause future performance to be different than anticipated, reference is made to Factors Affecting "Forward-Looking Statements" and Part 1A – Risk Factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 and Factors Affecting "Forward-Looking Statements" in Part I, Item 2 in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2022.

    Oppenheimer Holdings Inc.

    Consolidated Income Statements (Unaudited)

    ('000s, except number of shares and per share amounts)











































    For the Three Months Ended

    June 30,



    For the Six Months Ended

    June 30,





    2022



    2021



    % Change



    2022



    2021



    % Change

    REVENUE

























    Commissions

    $             94,378



    $             96,171



    (1.9)



    $         192,699



    $         209,642



    (8.1)



    Advisory fees

    107,405



    111,152



    (3.4)



    223,171



    215,648



    3.5



    Investment banking

    16,653



    104,742



    (84.1)



    55,123



    229,243



    (76.0)



    Bank deposit sweep income

    14,845



    3,712



    299.9



    19,199



    7,720



    148.7



    Interest

    11,789



    8,909



    32.3



    21,306



    17,575



    21.2



    Principal transactions, net

    1,258



    6,305



    (80.0)



    3,622



    17,170



    (78.9)



    Other

    (9,106)



    9,302



    *



    (11,870)



    16,577



    *



    Total revenue

    237,222



    340,293



    (30.3)



    503,250



    713,575



    (29.5)

    EXPENSES

























    Compensation and related expenses

    177,979



    231,140



    (23.0)



    364,010



    486,741



    (25.2)



    Communications and technology

    20,896



    19,172



    9.0



    42,481



    39,779



    6.8



    Occupancy and equipment costs

    14,554



    15,225



    (4.4)



    29,244



    30,407



    (3.8)



    Clearing and exchange fees

    6,242



    5,155



    21.1



    12,218



    11,430



    6.9



    Interest

    3,628



    2,448



    48.2



    6,140



    5,095



    20.5



    Other

    20,092



    23,985



    (16.2)



    41,113



    44,828



    (8.3)



    Total expenses

    243,391



    297,125



    (18.1)



    495,206



    618,280



    (19.9)



























    Pre-tax Income (Loss)

    (6,169)



    43,168



    *



    8,044



    95,295



    (91.6)

    Income taxes provision (benefit)

    (1,449)



    12,009



    *



    2,986



    25,478



    (88.3)

    Net Income (Loss)

    $              (4,720)



    $             31,159



    (115.1)



    $             5,058



    $           69,817



    (92.8)



























    Less: Net income (loss) attributable to non-controlling interest, net of tax

    (846)



    —



    *



    (360)



    —



    *

    Net income (loss) attributable to Oppenheimer Holdings Inc.

    $              (3,874)



    $             31,159



    *



    $             5,418



    $           69,817



    (92.2)



























    Earnings (Loss) per share attributable to Oppenheimer Holdings Inc.



















    Basic

    $                (0.32)



    $                 2.46



    *



    $               0.44



    $               5.53



    (92.0)



    Diluted

    $                (0.32)



    $                 2.28



    *



    $               0.41



    $               5.17



    (92.1)



























    Weighted average number of common shares outstanding



















    Basic

    11,980,115



    12,689,191



    (5.6)



    12,222,527



    12,634,464



    (3.3)



    Diluted

    11,980,115



    13,681,146



    (12.4)



    13,141,538



    13,495,589



    (2.6)



























    Period end number of common shares outstanding

    11,370,609



    12,692,311



    (10.4)



    11,370,609



    12,692,311



    (10.4)

                     * Percentage not meaningful

     

    Cision View original content:https://www.prnewswire.com/news-releases/oppenheimer-holdings-inc-reports-second-quarter-2022-earnings-301595837.html

    SOURCE Oppenheimer Holdings Inc.

    Get the next $OPY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OPY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OPY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings

    NEW YORK, Jan. 30, 2026 /CNW/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 million for the fourth quarter of 2024, an increase of 25.9%.  For the year ended December 31, 2025, the Company reported net income of $148.4 million or $14.13 basic earnings per share compared with net income of $71.6 million or $6.91 basic earnings per share for the year en

    1/30/26 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    OPPENHEIMER HOLDINGS INC. DECLARES SPECIAL DIVIDEND

    NEW YORK, Dec. 12, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will be approximately $10.5 million. The special dividend will be funded through OPY's existing cash management activities. Robert S. Lowenthal, President and Chief Executive Officer, commented: "We are pleased to recognize the year's operating results and our improved financial position through the announcement of a special dividend of $1

    12/12/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.

    The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areas NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City. Biliouris comes to Oppenheimer from BMO Capital Markets, where he was a Director, mainly covering the genetic medicines space. Before BMO, he was a VP in Biotech Research at Morgan Stanley and worked in drug development and produc

    12/8/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Lowenthal Robert S bought $3,056 worth of Class A non-voting common stock (46 units at $66.88) (SEC Form 5)

    5 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    2/9/26 4:11:27 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Lowenthal Albert G bought $11,930 worth of Class A non-voting common stock (178 units at $66.88) (SEC Form 5)

    5 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    2/9/26 4:11:08 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Director Lowenthal Robert S acquired 35,505 units of Class A non-voting common stock, increasing direct ownership by 38% to 129,608 units (SEC Form 4)

    4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    1/29/26 4:48:48 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    SEC Filings

    View All

    Oppenheimer Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    2/2/26 10:01:01 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    1/30/26 8:13:15 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    12/12/25 8:13:58 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oppenheimer Holdings, Inc. (Amendment)

    SC 13G/A - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)

    9/23/21 3:31:42 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G filed by Oppenheimer Holdings, Inc.

    SC 13G - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)

    6/25/21 2:44:05 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Financials

    Live finance-specific insights

    View All

    Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings

    NEW YORK, Jan. 30, 2026 /CNW/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 million for the fourth quarter of 2024, an increase of 25.9%.  For the year ended December 31, 2025, the Company reported net income of $148.4 million or $14.13 basic earnings per share compared with net income of $71.6 million or $6.91 basic earnings per share for the year en

    1/30/26 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    OPPENHEIMER HOLDINGS INC. DECLARES SPECIAL DIVIDEND

    NEW YORK, Dec. 12, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will be approximately $10.5 million. The special dividend will be funded through OPY's existing cash management activities. Robert S. Lowenthal, President and Chief Executive Officer, commented: "We are pleased to recognize the year's operating results and our improved financial position through the announcement of a special dividend of $1

    12/12/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. Reports Third Quarter 2025 Earnings

    NEW YORK, Oct. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the third quarter of 2025, compared with net income of $24.5 million or $2.38 basic earnings per share for the third quarter of 2024. Third quarter 2025 results were significantly impacted by higher pre-tax compensation expenses for liability-based awards totaling $13.5 million or $0.95 basic earnings per share (after tax), attributable to an increase in the OPY Class A share price (increased $8.30 per share during the quarter). Revenue for the third quarter of 2025 was $424.4 million, an increase of 13.7%, comp

    10/31/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Leadership Updates

    Live Leadership Updates

    View All

    Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.

    The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areas NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE:OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City. Biliouris comes to Oppenheimer from BMO Capital Markets, where he was a Director, mainly covering the genetic medicines space. Before BMO, he was a VP in Biotech Research at Morgan Stanley and worked in drug development and produc

    12/8/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer & Co. Inc. Appoints Keith Peterson As Head of Cash Equity Sales and Trading

    Veteran equity markets leader joins to oversee trading operations and advance cross-platform growth initiatives NEW YORK, Nov. 17, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. – a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings (NYSE:OPY) — today announced that Keith Peterson has joined the firm as Managing Director and Head of Cash Equity Sales and Trading. He will report to John Hellier, Senior Managing Director and Head of Equities. In this role, Peterson will oversee all supervisory and operational activities for Oppenheimer's equity sales and trading team, working closely with other leaders in the Equities division and across the firm to ensure continued

    11/17/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Announces the Appointment of Public Finance Banker Guy T. Logan as Managing Director, Head of Infrastructure & Mid-Atlantic Region

    Addition of respected industry veteran highlights the rapid expansion of the firm's Public Finance team NEW YORK, Oct. 29, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE:OPY), today announced it has hired Guy T. Logan to serve as Managing Director, Head of Infrastructure & Mid-Atlantic Region within the firm's Public Finance Investment Banking Division. He will report to Beth Coolidge, Managing Director and Head of Public Finance. Logan joins Oppenheimer with more than 30 years of municipal finance experience. Over the course of his career, he has served as senior or lead banker on more th

    10/29/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance